Clinical Trial Update: Open-label Leucovorin Pharmacokinetic Study in Patients Receiving High Dose Methotrexate With or Without Voraxaze [Phase 1]

View source ↗

Summary

Open-label pharmacokinetic study of leucovorin in patients receiving high-dose methotrexate, with or without Voraxaze, completed Phase 1.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Osteosarcoma

Drugs mentioned

• Leucovorin (folinic acid)
• Voraxaze (glucarpidase)

Snippet

Sponsor: BTG International Inc. | Conditions: Osteosarcoma, Leukemia | Phase 1 | Status: COMPLETED | Results posted: 2014-07-03